Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VKTX
VKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VKTX News
Vertex's $10B Crinetics Acquisition Sparks Biotech M&A Speculation
6h ago
stocktwits
Investment Outlook on Genetic Engineering and Weight Loss Innovations
21h ago
Fool
Viking Therapeutics Clinical Trial Outlook Analysis
2d ago
Fool
Comparative Investment in Gene Editing and Metabolic Medicine
2d ago
Fool
Investment Outlook for CRISPR and Viking Therapeutics
2d ago
NASDAQ.COM
Viking's VK2735 Shows Significant Weight Loss Potential
2d ago
NASDAQ.COM
Viking Therapeutics Faces Intense Competition in Obesity Drug Market
3d ago
Fool
Viking Therapeutics Faces Market Challenges Ahead of VK2735 Launch
3d ago
NASDAQ.COM
Market Outlook for Viking Therapeutics by 2030
3d ago
Yahoo Finance
Viking Therapeutics' Prospects in the Weight Loss Drug Market
4d ago
Fool
Viking Therapeutics Stock Rises on Optimism for New Drug Developments
4d ago
Fool
Viking's VK2735 Drug Shows Promising Outlook
4d ago
NASDAQ.COM
Eli Lilly Stock Surges on Strong Drug Approvals and Market Position
5d ago
NASDAQ.COM
Viking Therapeutics Stock Price Analysis
6d ago
NASDAQ.COM
Viking Therapeutics Shares Surge 27% with Promising Weight Loss Drug Trials
6d ago
Fool
ADMA Biologics Shows Promising Profitability Outlook
Jun 29 2026
NASDAQ.COM
Show More News
